Biofilm producing multidrug resistant acinetobacter baumannii: An emerging challenge

Journal of Clinical and Diagnostic Research

Volumn 9, Issue 1, 2015, Pages DC08-DC10

  Badave, Gitanjali Kailas ^a   Dhananjay, Kulkarni ^a  

^a Konaseema institute of medical sciences and research foundation   (India)

Author keywords

A. baumannii; Antimicrobial susceptibility; Biofilm; BlaPER 1; Exopolysac charide; Microtitre plate assay; Multiple drug resistance; Nosocomial

Indexed keywords

AMIKACIN; CEFTAZIDIME; CIPROFLOXACIN; IMIPENEM; PIPERACILLIN; SULTAMICILLIN;

ACINETOBACTER BAUMANNII; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM DETECTION; BACTERIUM ISOLATE; BACTERIUM ISOLATION; BIOFILM; DISK DIFFUSION; MULTIDRUG RESISTANCE; NONHUMAN;

ACINETOBACTER BAUMANNII;

EID: 84920279263     PISSN: 2249782X     EISSN: 0973709X     Source Type: Journal    
DOI: 10.7860/JCDR/2015/11014.5398     Document Type: Article

References (25)

1. Karlowsky JA, Draghi DC, Jones ME, Thornsberry C, Friedland IR, Sahm D. Surveillance for antimicrobial susceptibility among clinical isolates of Pseudomonas aeruginosa and Acinetobacter baumannii from hospitalized patients in the United States, 1998-2001. Antimicrob Agents Chemother. 2003;47:1681-88.
2. Joly Guillou ML. Clinical impact and pathogenicity of Acinetobacter. Clin Microbiol Infect. 2005;11:868-73.
3. Peleg AY, Seifert H, Paterson DL. Acinetobacter baumannii: emergence of a Successful pathogen. Clin Microbiol Rev. 2008;21:538-82.
4. Rodriguez BJ, Marti S, Soto S, Fernandez CF, Cisneros JM, Pachon J. Biofilm formation in Acinetobacter baumannii: associated features and clinical implications. Clin Microbiol Infect. 2008;14(3): 276-78.
5. Rahbar MR, Rasooli I, Gargari SL, Amani J, Fattahian Y.In silico analysis of antibody triggering biofilm associated protein in Acinetobacter baumannii. Journal of Theoretical Biology. 2010;266(2):275-90.
6. Winn WC, Koneman EW, Allen SD, Janda WM, Schreckenberger PC, Woods GL, et al. The Non Fermentative Gram Negative Bacilli. In: Koneman's Color Atlas and Textbook of Diagnostic Microbiology. 6th Ed. Philadelphia, Lippincott Company Williams and Wilkins; 2006: 353-57.
7. Gerner Smidt P, Tjernberg I, Ursing J. Reliability of phenotypic tests for identification of Acinetobacter species. J Clin Microbiol. 1991;29:277-82.
8. Collee JG, Miles RS, Watt B. Test for identification of bacteria, in Chapter: 7 Mackie & McCartney's Practical Medical Microbiology14th ed. In: JG Collee, AG Fraser, BP Marmion, A Simmons, Editors. Churchill Livingstone: Indian Reprint; 2008:131-49.
9. Bauer AW, Kirby WM, Sherris JC, Turuk M. Antimicrobial susceptibility testing by standardized single disc method. Am J Clin Pathol. 1966;45(4):493-96.
10. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility testing; Twenty third Informational Supplement. CLSI document M100-S23.Wayne, PA:Clinical and Laboratory Standards Institute; 2013.
11. Toledo AA, Valle J, Solano C, Arrizubieta MJ, Cucarella C, Lamata M, et al. The enterococcal surface protein, Esp, involved in Enterococcus faecalis biofilm formation. Appl Environ Microbiol. 2001;6:4538-45.
12. Christensen GD, Simpson WA, Younger JJ, Baddour LM, Barrett FF, Melton DM, et al. Adherence of coagulase-negative staphylococci to plastic tissue culture plates: a quantitative model for the adherence of staphylococci to medical devices. J Clin Microbiol. 1985;22(6):996-1006.
13. Bergone Berezin E, Towner KJ. Acinetobacter spp. as Nosocomial Pathogens: Microbiological, Clinical, and Epidemiological Features. Clin Microbiol Rev. 1996;9:148-65.
14. Jawad A, Seifert H, Snelling AM, Heritage J, Hawkey PM. Survival of Acinetobacter baumannii on dry surfaces: comparison of outbreak and sporadic isolates. J Clin Microbiol. 1998;36:1938-41.
15. Wendt C, Dietze B, Dietz E, Ruden H. Survival of Acinetobacter baumannii on dry surfaces. J Clin Microbiol. 1997;35:1394-97.
16. Costerton JW, Stewart PS, Greenberg EP. Bacterial biofilms: a common cause of persistent infections. Science. 1999;284:1318-22.
17. Lewis K. Riddle of biofilm resistance. Antimicrob Agents Chemother. 2001; 45:999-1007.
18. Donlan RM, Costerton JW. Biofilms: survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev. 2002;15:167-93.
19. Rao RS, Karthika RU, Singh SP, Shashikala P, Kanungo R, Jayachandran S, et al. Correlation between biofilm production and multiple drug resistance in imipenem resistant clinical isolates of Acinetobacter baumannii. Indian J Med Microbiol. 2008;26:333-37.
20. Gurung J, Khyriem AB, Banik A, Lyngdoh WV, Choudhury B, Bhattacharyya P. Association of biofilm production with multidrug resistance among clinical isolates of Acinetobacter baumannii and Pseudomonas aeruginosa from intensive care unit. Indian J Crit Care Med. 2013;17:214-18.
21. Nahar A, Anwar S, Ruhul M. Association of Biofilm Formation with Antimicrobial Resistance Among the Acinetobacter Species in A Tertiary Care Hospital in Bangladesh. J Medicine. 2013;14:28-32.
22. Shigeta M, Tanaka G, Komatsuzawa H, Sugai M, Suginaka H, Usui T. Permeation of antimicrobial agents through Pseudomonas aeruginosa biofilm: a simple method. Chemotherapy. 1997;43(5):340-45.
23. Moniri R, Kheltabadi FR, Shajari G, Nazem S, Ghasemi A. Molecular Epidemiology of Aminoglycoside Resistance in Acinetobacter Spp.with Emergence of Multidrug-Resistant Strains. Iranian J Publ Health. 2010;39(2):63-68.
24. Erac B, Yilmaz FF, Hosgor LM, Ozturk I, Aydemir S. Investigation of the virulence factors of multidrug-resistant Acinetobacter baumannii isolates. Mikrobiyol Bul. 2014;48(1):70-81.
25. Lee HW, Koh YM, Kim J. Capacity of multidrug-resistant clinical isolates of Acinetobacter baumannii to form biofilm and adhere to epithelial cell surfaces. Clin Microbiol Infect. 2008; 14:49-54.